RxGenomix’s pharmacogenomic reports include genetic health risk information that has not been reviewed by the FDA. The ExactMeds^® pharmacogenomic service leverages advanced genotype data to identify clinically relevant variants via patient saliva DNA for the purpose of understanding one’s health risk via medication utilization. The ExactMeds^® program is not intended to diagnose any disease. A patient’s ethnicity may affect the relevance of each report and how one’s genetic health risk results are interpreted. Information delivered via the ExactMeds^® service is not intended for a patient to independently act upon a medical decision, but rather to inform and provide the genetic risk information to share directly with their licensed provider.  The ExactMeds^® pharmacogenomic reports are not intended to tell a patient anything about their risk for developing a disease in the future.  

The ExactMeds^® pharmacogenomic service utilizes genotyping data to identify medication risk factors for the purpose of reporting and interpreting to inform discussions with a healthcare professional.  The ExactMeds^® pharmacogenomic report provides certain information about variants associated with metabolism of some therapeutics and provides interpretive drug information regarding the potential effect of those medications. 

Warning: Pharmacogenomic test results should not be used to start, stop, or change any course of treatment without consulting with a patient’s provider. The ExactMeds^® pharmacogenomic service is not a substitute for an appointment with a patient’s healthcare professional. For important information and limitations regarding pharmacogenomic testing, please visit: How Pharmacogenomics (PGx) Works – RxGenomix